According to the research report titled ‘Bone Growth Stimulators Market Size By Product (Bone Growth Stimulation Devices {External Bone Growth Stimulators [Combined Magnetic Field Devices, Capacitive Coupling Devices, Pulsed Electromagnetic Field Devices], Implanted Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators}, Bone Morphogenetic Proteins, Platelet-Rich Plasma), By End-use (Hospitals, Ambulatory Surgical Centers), By Application (Spinal Fusion Surgeries, Delayed Union & Non-union Bone Fractures, Oral And Maxillofacial Surgeries), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Spain, Italy, China, India, Japan, Australia, Singapore, Brazil, Mexico, South Africa, Saudi Arabia), Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report, the global bone growth stimulators market is expected to be worth USD 1.2 billion by the year 2025.
 

According to the report, rising prevalence of bone-related disorders along with rising number of trauma cases are major factors driving the bone growth stimulators market growth. There has been an upsurge in fracture cases due to violence, sport injuries and road accidents among others. This factor along with advancements in technology pertaining to bone growth stimulators are further aiding the market expansion.
 

Favorable government reforms which promote such medical products along with rising R&D activities are also stimulating the industry outlook. However, unfavorable reimbursement policies and numerous cases of product recall may hinder the market growth.
 

As per product type, external bone growth stimulators market segment held 40% share in the year 2018 and is expected to register continuous growth during the forecast period. These devices are a non-invasive solution to delayed union & non-union of bones, thereby facilitating the business scenario.  On the other hand, the platelet-rich plasma segment will grow considerably in the forthcoming years due to minimum side-affects associated with product usage.
 

Based on the application spectrum, delayed union & non-union bone fractures segment held the largest share of bone growth stimulators market in the year 2018 owing to rising prevalence of osteoporosis. The report cites that spinal fusion surgeries segment is presumed to grow with a CAGR of 6% during the period of 2019-2025. Factors such as high occurrence of spinal injuries, growing geriatric population and increased pervasiveness of spinal stenosis and herniated disc are fueling the segmental growth.
 

Citing the end-use landscape, hospitals segment held 47% share in the bone growth stimulators industry in the year 2018 and will witness consistent growth during the forecast period. Surging investments in healthcare infrastructure along with availability of skilled medical professionals are augmenting the demand for the product in hospitals across the globe.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2144050/
 

Considering the geographical landscape, the U.S. bone growth stimulators industry is predicted to grow with 5.9% CAGR between 2019 and 2025. Growing occurrences of osteoporosis, availability of skilled professionals, and rising adoption of technologically advanced devices are contributing towards the popularity of the bone growth stimulators across the country.
 

As per the report, India bone growth stimulator industry is expected to expand with a CAGR of 9.2% through 2025. Rising healthcare infrastructure, growing elderly population and high occurrence of road accidents are driving the market growth.
 

The prominent companies operating in the bone growth stimulators market are Synergy Orthopedics, Bioventus LLC, Zimmer Biomet Holdings Inc., Orthofix International N.V., TERUMO, DePuy Synthes Companies, Stryker, and Medtronic.